A Nature Cell Biology study shows that vitamin B2 metabolism helps cancer cells evade ferroptosis by stabilizing ferroptosis ...

ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...

Health and Pharma is a pioneering news and communications platform focused on health science, biotechnology, and pharmaceutical developments.

Oregon Therapeutics & Lantern Pharma launch a strategic AI collaboration to optimize XCE853, a novel cancer drug candidate. Demonstrating efficacy in solid and hematological cancers, XCE853 is poised ...

In a historic decision, the FDA has approved Casgevy, the first-ever CRISPR-based gene editing therapy for sickle cell disease (SCD), marking a milestone in medical science. With the potential to ...

Oncolytic viruses are a very promising class of therapeutic agents, with a broad range of types. They not only infect and kill cancer cells, but also modulate the tumor micro-environment to enhance ...

Rznomics has received FDA Orphan Drug Designation for RZ-001, a novel RNA-based therapy for Hepatocellular carcinoma. RZ-001 employs advanced RNA editing to target and suppress cancer growth, showing ...

The Phase III SUNMO trial could mark a breakthrough for transplant-ineligible patients with relapsed or refractory large B-cell lymphoma. In this ONCOLife interview, we spoke with Dr. Jason Westin, ...

In a landmark development, Bayer AG and AskBio announced the completion of their 18-month Phase Ib trial of AB-1005, a novel gene therapy for Parkinson's disease, yielding encouraging results.